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OBJECTIVES We sought to determine the prognostic value of exercise echocardiography in the elderly.
BACKGROUND Limited data exist regarding the prognostic value of exercise testing in the elderly, a
population which may be less able to exercise and is at increased risk of cardiac death.
METHODS Follow-up (2.9 6 1.7 years) was obtained in 2,632 patients $65 years who underwent
exercise echocardiography.
RESULTS There were 1,488 (56%) men and 1,144 (44%) women (age 72 6 5 years). The rest ejection
fraction was 56 6 9%. Rest wall motion abnormalities were present in 935 patients (36%).
The mean work load was 7.7 6 2.3 metabolic equivalents (METs) for men and 6.5 6 1.9
METs for women. New or worsening wall motion abnormalities developed with stress in
1,082 patients (41%). Cardiac events included cardiac death in 68 patients and nonfatal
myocardial infarction in 80 patients. The addition of the exercise electrocardiogram to the
clinical and rest echocardiographic model provided incremental information in predicting
both cardiac events (chi-square 5 77 to chi-square 5 86, p 5 0.003) and cardiac death
(chi-square 5 71 to chi-square 5 86, p , 0.0001). The addition of exercise echocardio-
graphic variables, especially the change in left ventricular end-systolic volume with exercise
and the exercise ejection fraction, further improved the model in terms of predicting cardiac
events (chi-square 5 86 to chi-square 5 108, p , 0.0001) and cardiac death (chi-square 5
86 to chi-square 5 99, p 5 0.004).
CONCLUSIONS Exercise echocardiography provides incremental prognostic information in patients $65 years
of age. The best model included clinical, exercise testing and exercise echocardiographic
variables. (J Am Coll Cardiol 2001;37:1036–41) © 2001 by the American College of
Cardiology
It has been estimated that the proportion of the U.S.
population $65 years of age will increase progressively and,
in the year 2050, will comprise 79 million people (1). In the
elderly, the prevalence of coronary artery disease is high, and
cardiovascular disease is the leading cause of death. How-
ever, elderly patients may be less able to exercise (2), which
makes identification of high risk patients more difficult in
this age group.
Limited data on the prognostic value of exercise testing in
elderly patients are available (2). The purposes of the
present study were to determine the prognostic value of
exercise electrocardiography and exercise echocardiography
in patients $65 years of age and to assess the incremental
value of exercise electrocardiography and exercise echocar-
diography in predicting cardiac events in this population.
METHODS
Patients. From January 1990 to December 1995, 6,420
patients were referred for clinically-indicated exercise echo-
cardiography. Of the patients, 234 (4%) had inadequate
echocardiographic images (no echocardiographic evidence
of ischemia and two or more segments not visualized), and
142 patients (2%) refused to participate in the study. Of the
remaining 6,044 patients, 2,716 were at least 65 years of age.
Follow-up data were obtained in 2,632 of these patients
(97%); these comprise the study group. No statistically
significant differences were present in these patients, as
compared with patients without follow-up.
Exercise echocardiography. All patients underwent
symptom-limited treadmill exercise testing according to: 1)
the Bruce protocol in 2,181 (83%); 2) the Naughton
protocol in 259 (10%); and 3) the modified Bruce protocol
in 192 (7%). Work load was measured by metabolic equiv-
alents (METs). Two-dimensional echocardiographic im-
ages were obtained from the parasternal and apical windows
before and immediately after exercise (3).
Both quad-screen digitized and videotape-recorded im-
ages were used for interpretation of all studies (4). The
ejection fraction (EF) at rest was measured using a previ-
ously validated modification of the method of Quinones et
al. (5) or by visual estimation (6); after exercise, it was
measured by visual estimation. Regional wall motion was
assessed semiquantitatively by an experienced echocardiog-
rapher (7) who had no knowledge of the clinical informa-
tion. Wall motion at rest and with exercise in each of 16
segments was scored 1 through 5 (8). The wall motion score
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index (WMSI) was determined at rest and peak exercise as
the sum of the segmental scores divided by the number of
visualized segments. The development of new or worsening
wall motion was considered indicative of ischemia. A wall
motion abnormality present at rest and unchanged with
exercise was classified as “fixed.” The percentage of seg-
ments that were abnormal was calculated as follows: abnor-
mal (ischemia or fixed abnormality) segments divided by the
number of visualized segments, multiplied by 100%. The
change in left ventricular end-systolic volume (LVESV)
from rest to exercise was determined by visual estimation,
using a side-by-side comparison of rest and exercise digi-
tized images, and was recorded as normal (decrease in
LVESV) or abnormal (no change or increase) (9).
Interobserver and intraobserver variabilities. To assess
the interobserver variability, two independent observers
assessed the EF and LVESV responses in a sample of 20
tests randomly selected according to a systematic sampling
framework to represent a range of responses and image
qualities. Intraobserver variability was determined similarly
in a sample of 20 tests. A third independent observer
measured EF and LVESV at rest and during exercise by
using the modified biplane Simpson method (Image Vue,
Nova Microsonics, Allendale, New Jersey).
Follow-up. Follow-up was obtained by mailed question-
naires and scripted telephone interviews. The events were
verified by contacting the patients’ physician and by review-
ing medical records and death certificates. The end points
were cardiac events, including myocardial infarction (MI)
and cardiac death. Sudden death occurring without another
explanation was included as cardiac death. Patients who had
coronary revascularization before other events were elimi-
nated from the study at the time of revascularization.
Statistical analysis. Continuous variables were reported as
the mean value 6 SD, and categoric variables as percent-
ages. The level of agreement (intraobserver, interobserver
and intermethod) for exercise EF was assessed by the
method of Bland and Altman. Cohen’s kappa statistic was
used to assess the level of agreement regarding the subjective
categorization of the LVESV response to exercise. Survival
free of the end point of interest was estimated by using the
Kaplan-Meier method. The association between the clinical
and exercise echocardiographic variables and the end points
was assessed in the Cox proportional hazards framework by
using the variables listed in Table 1. The variables were
selected in a stepwise forward selection manner with entry
and retention set at a significance (p) level of 0.05 and
summarized as the risk ratio (RR) with corresponding 95%
confidence interval (CI).
The incremental value of exercise echocardiographic in-
formation over clinical, rest echocardiographic and exercise
electrocardiographic (ECG) data was assessed in three
modeling steps. The first step consisted of fitting a multi-
variable model of only clinical and rest echocardiographic
data. The variables selected from the first step were then
used as baseline risk factors, and exercise ECG variables
were added in a stepwise forward selection manner. The
predictive accuracy of each modeling step was assessed by
using a modified concordance statistic (C-index) for cen-
sored data (10). This statistic estimates the probability of
correctly ordering the event times of two randomly selected
subjects given their respective model covariates. A signifi-
cant improvement in model prediction was based on the
likelihood ratio statistic, which follows a chi-square distri-
bution.
RESULTS
Study group. The study group consisted of 1,488 men
(56%) and 1,144 women (44%); their mean age was 72 6 5
years (range 65 to 91). Cardiovascular risk factors included:
hypercholesterolemia in 1,438 patients (55%), hypertension
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram
EF 5 ejection fraction
LA 5 limits of agreement
LVESV5 left ventricular end-systolic volume
METs 5 metabolic equivalents
MI 5 myocardial infarction
RR 5 risk ratio
WMSI 5 wall motion score index
Table 1. Univariable Predictors of Cardiac Events (Cox
Regression Analysis) in Patients Undergoing Exercise
Stress Echocardiography
Variable RR 95% CI p Value
Clinical data
Previous MI 2.69 1.95–3.72 0.0001
Diabetes mellitus 2.05 1.36–3.09 0.0006
Age* 1.79 1.22–2.37 0.005
Previous CABG 1.87 1.32–2.66 0.0004
Male gender 1.64 1.16–2.33 0.005
Q-waves on rest ECG 2.10 1.49–2.95 0.0001
Rest echocardiographic data
EF† 0.60 0.54–0.66 0.0001
Rest WMSI 3.62 2.67–4.91 0.0001
Exercise ECG data
Exercise-induced angina 1.57 0.99–2.50 0.005
Positive exercise ECG 1.05 0.72–1.55 0.79
Work load‡ 0.85 0.80–0.92 0.001
Exercise echocardiographic data
Percent abnormal segments with
exercise§
6.63 4.20–10.5 0.0001
Abnormal LVESV response 3.57 2.56–5.00 0.0001
Exercise WMSI\ 3.57 2.70–4.73 0.0001
Change in WMSI\ 2.89 1.66–5.02 0.0002
Exercise EF† 0.66 0.60–0.74 0.0001
Change in EF† 0.66 0.54–0.74 0.0001
*Per decade. †Per 10-U change in ejection fraction (EF). ‡Per 1 MET change in work
load. §Per 10% abnormal segments. \Per 1-U change in wall motion score index
(WMSI). Variables that were not predictive included angina, hypertension and
previous coronary angioplasty.
CABG 5 coronary artery bypass graft surgery; CI 5 confidence interval;
LVESV 5 left ventricular end-systolic volume; RR 5 risk ratio; other abbreviations
as in Table 1.
1037JACC Vol. 37, No. 4, 2001 Arruda et al.
March 15, 2001:1036–41 Exercise Echocardiography in the Elderly
in 1,351 (51%), a family history of premature coronary
artery disease in 899 (34%), diabetes mellitus in 288 (11%)
and smoking in 173 (7%). Of the patients, 629 (24%) had a
history of typical angina, 453 (17%) had previous coronary
artery bypass graft surgery, 308 (12%) had previous coronary
angioplasty and 628 (24%) had previous MI. The baseline
ECG was abnormal in 1,696 patients (64%): 1,165 (44%)
had ST-T wave changes, 528 (20%) had a previous Q-wave
MI and 329 (13%) had other abnormalities.
Exercise echocardiography. The patients’ characteristics
and exercise test results are summarized in Table 2. The
mean work load was 7.7 6 2.3 METs for men and 6.5 6
1.9 METs for women (p 5 0.0001). The WMSI was 1.2 6
0.4 at rest and 1.3 6 0.4 with exercise. The EF increased
from 56 6 9% to 62 6 13% with exercise (p 5 0.001). The
EF increased in 1,988 patients (76%). The LVESV did not
decrease in 676 patients (26%).
Interobserver and intraobserver variabilities and volu-
metric data. There was 100% intraobserver agreement
(kappa 5 1.0 6 0.0009) and 85% interobserver agreement
(kappa 5 0.8 6 0.12) regarding the subjective interpretation
of the LVESV response to exercise. Volumetric assessment
revealed a decrease in LVESV in 18 (95%) of 19 tests that
were subjectively classified as a normal LVESV response,
and an increase or lack of change in 15 (81%) of 21 tests
subjectively classified as abnormal. The volumetric assess-
ment for the two groups was significantly different (214 6
13 vs. 2 6 25 ml, p 5 0.001). The intraobserver and
interobserver differences in the subjective assessment of
exercise EF were 0.1 6 2.3 (95% limits of agreement [LA]
25%, 5%) and 0.7 6 3.8 (95% LA 25%, 10%), respectively.
The mean difference between the subjective interpretation
of the exercise EF and the volumetric assessment was 0.3 6
3.3 (95% LA 26%, 7%).
Outcomes. During a median follow-up period of 2.6 years
(mean 2.9 6 1.7), there were 148 cardiac events, including
cardiac death in 68 patients and nonfatal MI in 80 patients.
Of the patients, 274 underwent revascularization before any
cardiac event. For cardiac death, the estimated one- and
five-year event-free survival rates were 99.5% and 95.4%,
respectively. For cardiac events, the corresponding rates
were 98.8% and 88.9%.
Predictors of cardiac events. The univariate associations
with cardiac events are shown in Table 1. Multivariable
predictors of cardiac events are reported in Table 3. When
exercise EF and LVESV responses were excluded from
consideration, the significant predictors were diabetes mel-
litus (RR 1.71 [CI 1.13 to 2.58], p 5 0.004), previous MI
(RR 1.56 [CI 1.09 to 2.24], p 5 0.012), exercise WMSI
Figure 1. Survival free of cardiac events: effect of exercise LVESV
response. An increase or lack of decrease in LVESV with exercise was
associated with more cardiac events. LVESV 5 left ventricular end-systolic
volume.
Figure 2. Survival free of cardiac events: effect of exercise WMSI. More
events were observed with a higher exercise WMSI. WMSI 5 wall motion
score index.
Table 3. Multivariable Predictors of Cardiac Events in Patients
Undergoing Exercise Echocardiography
Variable RR 95% CI p Value
Abnormal LVESV response 1.98 1.32–2.96 0.0004
Diabetes mellitus 1.83 1.21–2.78 0.004
Previous MI 1.56 1.09–2.24 0.02
Age 1.48 1.08–2.02 0.01
Exercise EF 0.78 0.69–0.90 0.0003
Abbreviations as in Tables 1 and 2.
Table 2. Exercise Test Characteristics
Variable n (%)
Indication for test
Chest pain or dyspnea 1,629 (62%)
Known coronary artery disease 730 (28%)
Risk stratification before noncardiac surgery 136 (5%)
Multiple risk factors 71 (2.5%)
Recent MI 66 (2.5%)
Exercise ECG results
Negative 1,257 (48%)
Positive 619 (23%)
Nondiagnostic 756 (29%)
Exercise echocardiographic results
Normal 1,133 (43%)
Ischemia 557 (21%)
Fixed abnormality 417 (16%)
Fixed abnormality and ischemia 525 (20%)
ECG 5 electrocardiographic; MI 5 myocardial infarction.
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(RR 2.78 [CI 2.03 to 3.81], p 5 0.001) and work load (RR
0.89 [0.83 to 0.95], p 5 0.001). Figures 1 and 2 depict the
univariate impact of LVESV response and exercise WMSI
on survival free of cardiac events.
For cardiac death, the multivariable predictors are re-
ported in Table 4. When exercise EF and LVESV responses
to exercise were not considered, exercise WMSI (RR 3.48
[CI 2.25 to 5.38], p 5 0.001), age (RR 1.97 [CI 1.22 to
1.39], p 5 0.006), presence of Q-waves on the rest ECG
(RR 1.76 [CI 1.06 to 2.90], p 5 0.03) and work load (RR
0.81 [CI 0.72 to 0.92], p 5 0.0003) were predictors of
cardiac death.
To determine whether the prognostic ability of the final
models changed relative to the patient’s age, models with
and without interactions of age and the final models with
the linear predictor were fitted. The 1° of freedom test
values for the change in model chi-square were 0.73 (p 5
0.39) for “hard” cardiac events, including MI and cardiac
death, and 0.71 (p 5 0.40) for all cardiac events.
Incremental value of exercise echocardiography. Figure 3
(left) illustrates the incremental value of exercise electrocar-
diography and exercise echocardiography in predicting car-
diac events. Significant clinical factors consisted of age,
previous MI, diabetes mellitus and rest WMSI, which
provided a C-index of 69%. After forcing these clinical
variables into the model, work load (p 5 0.003) and
exercise-induced angina (p 5 0.04) added residual prognos-
tic information. When work load was added to the model,
exercise-induced angina was no longer significant. The
C-index of this model was 70%. After forcing the clinical
variables and work load into the model, all of the exercise
echocardiographic variables listed in Table 1 had significant
residual prognostic effects. Of these, an abnormal LVESV
response (p 5 0.0001) contributed the most to the previous
model; the C-index was 72%. When exercise EF and
LVESV response data were excluded, a change in WMSI
(p 5 0.001) had the greatest impact and similar predictive
accuracy.
Figure 3 (right) illustrates the incremental models for
cardiac death. The clinical and exercise ECG variables
selected were the same as those for cardiac events. Of the
exercise echocardiographic variables, the percentage of ab-
normal segments at exercise was the only variable that did
not have a statistically significant residual impact on out-
come (p 5 0.054). Of the remaining variables, a change in
EF (p 5 0.0001) had the greatest residual impact. After
excluding exercise EF and LVESV response data, a change
in WMSI (p 5 0.01) had the greatest impact on survival
free of cardiac events. The corresponding C-indexes were
78%, 81% and 82% for the three modeling steps.
DISCUSSION
Incremental value of exercise ECG and exercise echocar-
diogram. In this study of 2,632 patients $65 years of age,
both the exercise ECG and the exercise echocardiogram
provided significant incremental value, as compared with
the clinical and rest echocardiographic variables, for predict-
ing cardiac death and cardiac events. Exercise EF was an
independent predictor of both cardiac death and cardiac
events. An abnormal LVESV response to exercise was an
independent predictor of cardiac events.
It has been reported that for patients who can exercise,
exercise testing should be the test of choice over pharma-
cologic stress testing (11,12). The present study included a
large population of elderly patients who could exercise.
These patients were not limited by peripheral vascular
atherosclerosis, lung disease, osteoarticular abnormalities or
Table 4. Multivariable Predictors of Cardiac Death in Patients
Undergoing Exercise Echocardiography
Variable RR 95% CI
p
Value
Age 2.02 1.23–3.31 0.005
Q-wave on rest ECG 1.72 1.05–2.84 0.03
Work load 0.84 0.75–0.95 0.004
Exercise EF 0.63 0.54–0.73 0.0001
Abbreviations as in Tables 1 and 2.
Figure 3. Incremental value of exercise electrocardiography and exercise echocardiography (Echo) in predicting cardiac events (left) and cardiac death
(right). The addition of exercise ECG variables to the clinical and rest echocardiographic models significantly improved the models. The addition of exercise
echocardiographic variables further improved both models.
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other diseases that frequently promote disabilities in the
elderly. In this elderly population, exercise echocardiogra-
phy had incremental value additional to the clinical variables
of age, diabetes mellitus and previous MI and additional to
the exercise ECG.
Of the exercise ECG variables, work load was the most
important in predicting both cardiac events and cardiac
death. A positive exercise ECG and angina were not
predictive. Similarly, in a previous study of patients under-
going treadmill exercise testing, a higher work load was
associated with a reduction in the risk of cardiac events and
all-cause mortality (13). In a previous study of patients with
normal exercise echocardiography, inadequate work load
was an independent predictor of cardiac events (14).
Exercise echocardiographic predictors of events. Studies
in elderly patients enduring pharmacologic stress have
reported that the presence of abnormal results predicted
cardiac events (15,16). In our series, we not only classified
the results of exercise echocardiography as positive or
negative, but also considered additional variables including
WMSI, the percentage of segments that were abnormal and
changes in LVESV and EF. Among patients with estab-
lished coronary artery disease, rest left ventricular dysfunc-
tion has been described as a predictor of prognosis (17). In
our study population, rest WMSI contributed to the clinical
model but was not significant when exercise echocardio-
graphic variables were included.
In the present study, an abnormal exercise LVESV
response and exercise EF were independent predictors of
cardiac events. This is not surprising, as previous studies
using stress echocardiography (18) have shown that the
abnormal LVESV response to stress was associated with
significant coronary disease. In previous studies using radio-
nuclide ventriculography, a low exercise EF was associated
with the presence of extensive coronary artery disease
(19,20) and was a predictor of cardiac events (21). Limacher
et al. (22) described an abnormal exercise EF response using
both echocardiography and radionuclide ventriculography
in patients with multivessel coronary artery disease; good
agreement was noted for both techniques. Our study is the
first, to our knowledge, to describe exercise EF, as measured
by echocardiography, as an independent predictor of cardiac
events. In our study population, exercise WMSI was an
independent predictor of cardiac events if the variables of
abnormal LVESV and exercise EF were not considered.
These variables are similar, for they both reflect the extent
and severity of infarction and ischemia. Thus, in addition to
information on exercise capacity and segmental wall motion,
prognostically important information on the global ventric-
ular response to exercise can be obtained with exercise
echocardiography.
Study limitations. The limitations of our study include the
absence of a control group of patients ,65 years of age.
However, when the multivariable model was adjusted ac-
cording to age, the results were unchanged. The exercise EF
and LVESV responses were subjectively assessed. However,
we observed good intraobserver and interobserver agree-
ment in estimating both the EF and LVESV responses;
there was also good agreement with volumetric assessment.
The LVESV response has been previously been described
by Chuah et al. (9) as a predictor of cardiac events in
patients who underwent dobutamine stress echocardiogra-
phy. The exercise echocardiographic results were used in
managing patients; this may have reduced the prognostic
value of the test. Only MI and cardiac death were
considered as end points, because the decision for revas-
cularization might have been influenced by the test
results. Lastly, follow-up could be obtained in only 97%
of patients. However, patients unavailable for follow-up
did not differ in terms of clinical or exercise echocardio-
graphic variables.
Conclusions. In this population of 2,632 patients aged
$65 years, exercise electrocardiography, especially work
load, had incremental value, as compared with clinical and
rest echocardiographic variables, in identifying patients at
risk of cardiac events. However, the best model for predict-
ing cardiac events or cardiac death included the results of
exercise echocardiography.
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